Canagliflozin improves risk factors of metabolic syndrome...

Diabetes Metabolic Syndrome and Obesity Targets and Therapy 2017 / 01 Vol. Volume 10

Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome

Davies, Michael J, Merton, Katherine W, Vijapurkar, Ujjwala, Balis, Dainius A., Desai, Mehul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
Volume 10
Language:
english
Journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
DOI:
10.2147/dmso.s126291
Date:
January, 2017
File:
PDF, 1.56 MB
english, 2017
Conversion to is in progress
Conversion to is failed